GREASLEY; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for GREASLEY; Peter.The latest application filed is for "combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases".

Company Profile

0.1.7

GREASLEY; Peter - Molndal SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of Zibotentan And Dapagliflozin For The Treatment Of Endothelin Related Diseases App 20220023295 - GREASLEY; Peter ; et al.	2022-01-27
5, 6-diaryl-pyrazine-2-amide derivatives as CB.sub.1 antagonists Grant 7,342,019 - Berggren , et al. March 11, 2	2008-03-11
Splice Variant Cannabinoid Receptor (cb1b) App 20070117138 - Vu; Huy Khang ; et al.	2007-05-24
Screening assays for cannabinoid-ligand-type modulators of gpr55 App 20060194260 - Drmota; Tomas ; et al.	2006-08-31
1,5-Diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators App 20060122230 - Berggren; Anna Ingrid Kristina ; et al.	2006-06-08
4,5-diarylthiazole derivatives as cb-1 ligands App 20060122229 - Berggren; Anna Ingrid Kristina ; et al.	2006-06-08
Methods to identify true antagonists and inverse agonists of the cannabinoid receptor App 20050239133 - Greasley, Peter	2005-10-27
5 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists App 20050032808 - Berggren, Anna Ingrid Kristina ; et al.	2005-02-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.